Internal Medicine, Hematology & Oncology · Middletown, NY
NPI
1285635912
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
155 Crystal Run Rd
Middletown, NY, 10941
Phone (845) 703-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
181,010 services
Medicare patients, 2024
920
Average age 76
Drug cost, 2024
$5.4M
4,361 prescriptions
Company payments, 2023
$74.42
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert E Dinsmore was code J9271 (injection, pembrolizumab, 1 mg), 21,400 times for 26 patients. In total Robert E Dinsmore billed 181,010 services in 204 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,400 | 26 | $44.56 | $954K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 8,820 | 16 | $39.06 | $345K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 7,600 | 12 | $0.06 | $424 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,350 | 21 | $0.11 | $810 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 4,300 | 34 | $5.83 | $25K |
| J9267 Injection, paclitaxel, 1 mg | Office | 2,985 | 13 | $0.08 | $236 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 2,910 | 94 | $0.25 | $731 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,742 | 75 | $0.09 | $247 |
| 36415 Venipuncture Blood Collection | Office | 1,709 | 601 | $8.65 | $15K |
| Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 1,620 | 12 | $15.93 | $26K |
| 85025 Blood Count | Office | 1,593 | 585 | $7.60 | $12K |
| 80053 Clinical Chemistry | Office | 1,317 | 509 | $10.34 | $14K |
| 99213 Office E&M - Established | Office | 1,011 | 465 | $69.13 | $70K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 895 | 423 | $13.25 | $12K |
| 99214 Office E&M - Established | Office | 744 | 324 | $100.40 | $75K |
By year: 2022 $3.3M for 146,790 services; 2023 $4.7M for 205,943 services; 2024 $3.7M for 181,010 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,709 | 601 | $8.65 | $15K |
| 85025 Blood Count | 1,593 | 585 | $7.60 | $12K |
| 80053 Clinical Chemistry | 1,317 | 509 | $10.34 | $14K |
| 80061 Clinical Chemistry | 205 | 172 | $13.12 | $2,690 |
| 84443 Clinical Chemistry | 134 | 108 | $16.36 | $2,192 |
| 82607 Clinical Chemistry | 114 | 102 | $14.78 | $1,685 |
| 82728 Clinical Chemistry | 100 | 84 | $13.36 | $1,336 |
| 84466 Clinical Chemistry | 89 | 75 | $12.50 | $1,113 |
| 83036 Blood Count | 76 | 62 | $9.52 | $724 |
| 84153 Clinical Chemistry | 72 | 31 | $17.79 | $1,281 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert E Dinsmore prescribed most often to Medicare patients was Atorvastatin Calcium, with 266 prescriptions and refills. In total Robert E Dinsmore wrote 4,361 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 266 | 783 | 79 | $2,713 |
| Amlodipine Besylate Generic | 161 | 463 | 49 | $1,057 |
| Losartan Potassium Generic | 160 | 435 | 44 | $1,629 |
| Levothyroxine Sodium Generic | 147 | 349 | 38 | $1,877 |
| Eliquis Apixaban | 140 | 197 | 38 | $112K |
| Anastrozole Generic | 138 | 384 | 41 | $2,759 |
| Oxycodone Hcl Generic | 104 | 104 | 25 | $2,727 |
| Metoprolol Succinate Generic | 101 | 273 | 32 | $1,516 |
| Simvastatin Generic | 93 | 276 | 27 | $975 |
| Gabapentin Generic | 89 | 179 | 27 | $1,198 |
| Potassium Chloride Generic | 85 | 144 | 31 | $966 |
| Lisinopril Generic | 81 | 237 | 23 | $514 |
| Hydroxyurea Generic | 72 | 149 | 16 | $1,814 |
| Sertraline Hcl Generic | 71 | 169 | 19 | $550 |
| Omeprazole Generic | 69 | 179 | 21 | $745 |
Brand drugs: 668 claims; generic drugs: 3,679 claims; opioid claims: 204.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Robert E Dinsmore $74.42 ($74.42 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $74.42.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $74.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.